Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Slusher

Showing results (511-520 of 672) with videos related to

Pageof 68
Sort By:
British Journal of Pharmacology|July 6, 2019
A novel and potent brain penetrant inhibitor of extracellular vesicle releaseCamilo Rojas, Michal Sala, Ajit G Thomas, et al.
Journal of Medicinal Chemistry|August 5, 2022
Discovery of Orally Bioavailable and Brain-Penetrable Prodrugs of the Potent nSMase2 Inhibitor DPTIPArindom Pal, Sadakatali Gori, Seung-Wan Yoo, et al.
Pharmaceutics|October 27, 2022
D-DOPA Is a Potent, Orally Bioavailable, Allosteric Inhibitor of Glutamate Carboxypeptidase IISadakatali S Gori, Ajit G Thomas, Arindom Pal, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 15, 2011
Reduced BACE1 activity enhances clearance of myelin debris and regeneration of axons in the injured peripheral nervous systemMohamed H Farah, Bao Han Pan, Paul N Hoffman, et al.
Cancer Research|April 19, 2011
Comparison of neuropathy-inducing effects of eribulin mesylate, paclitaxel, and ixabepilone in miceKrystyna M Wozniak, Kenichi Nomoto, Rena G Lapidus, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|March 30, 2018
Patterns of acute bilirubin encephalopathy in Nigeria: a multicenter pre-intervention studyUdochukwu M Diala, Richard P Wennberg, Isa Abdulkadir, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against <i>Mycobacterium tuberculosis</i>Sadiya Parveen, Jessica Shen, Shichun Lun, et al.
Journal of Medicinal Chemistry|September 19, 2019
Investigation of Novel Primary and Secondary Pharmacophores and 3-Substitution in the Linking Chain of a Series of Highly Selective and Bitopic Dopamine D<sub>3</sub> Receptor Antagonists and Partial AgonistsAnver Basha Shaik, Vivek Kumar, Alessandro Bonifazi, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
The discovery and structure-activity relationships of indole-based inhibitors of glutamate carboxypeptidase IIBrian Grella, Jessica Adams, James F Berry, et al.
Biochemical Pharmacology|October 22, 2021
Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injuryCarolyn Tallon, Silvia Picciolini, Seung-Wan Yoo, et al.
Pageof 68

Showing results (511-520 of 672) with videos related to

Sort By:
Pageof 68
British Journal of Pharmacology|July 6, 2019
A novel and potent brain penetrant inhibitor of extracellular vesicle releaseCamilo Rojas, Michal Sala, Ajit G Thomas, et al.
Journal of Medicinal Chemistry|August 5, 2022
Discovery of Orally Bioavailable and Brain-Penetrable Prodrugs of the Potent nSMase2 Inhibitor DPTIPArindom Pal, Sadakatali Gori, Seung-Wan Yoo, et al.
Pharmaceutics|October 27, 2022
D-DOPA Is a Potent, Orally Bioavailable, Allosteric Inhibitor of Glutamate Carboxypeptidase IISadakatali S Gori, Ajit G Thomas, Arindom Pal, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 15, 2011
Reduced BACE1 activity enhances clearance of myelin debris and regeneration of axons in the injured peripheral nervous systemMohamed H Farah, Bao Han Pan, Paul N Hoffman, et al.
Cancer Research|April 19, 2011
Comparison of neuropathy-inducing effects of eribulin mesylate, paclitaxel, and ixabepilone in miceKrystyna M Wozniak, Kenichi Nomoto, Rena G Lapidus, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|March 30, 2018
Patterns of acute bilirubin encephalopathy in Nigeria: a multicenter pre-intervention studyUdochukwu M Diala, Richard P Wennberg, Isa Abdulkadir, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against <i>Mycobacterium tuberculosis</i>Sadiya Parveen, Jessica Shen, Shichun Lun, et al.
Journal of Medicinal Chemistry|September 19, 2019
Investigation of Novel Primary and Secondary Pharmacophores and 3-Substitution in the Linking Chain of a Series of Highly Selective and Bitopic Dopamine D<sub>3</sub> Receptor Antagonists and Partial AgonistsAnver Basha Shaik, Vivek Kumar, Alessandro Bonifazi, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
The discovery and structure-activity relationships of indole-based inhibitors of glutamate carboxypeptidase IIBrian Grella, Jessica Adams, James F Berry, et al.
Biochemical Pharmacology|October 22, 2021
Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injuryCarolyn Tallon, Silvia Picciolini, Seung-Wan Yoo, et al.
Pageof 68